Changing the world
UCLB is the commercialisation company of UCL and its partner NHS Trusts. We bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives.
UCLB spinout Orchard Therapeutics acquires rare disease gene therapy portfolio from GSK
The clinical-stage gene therapy company, announced its recent strategic agreement with GSK, to acquire its portfolio of approved and investigational rare disease gene therapies.
Novel method of analysis of stroke data
Latest news and highlights
Bringing innovation to life